Scoring System Stratifies Risk of Heart Failure in Patients With Acute LeukemiaMay 18th 2020
Baseline clinical characteristics coupled with measurable cardiac parameters can be used to predict the risk of heart failure among adults with acute leukemia who receive anthracycline-based therapy, according to recent study findings.
Chasing a Cure for GBM: Investigators Test Multiple Regimens in Novel TrialMay 14th 2020
Investigators of the first global adaptive phase 2/3 GBM Adaptive Global Innovative Learning Environment platform trial are implementing a multiarm, 2-stage approach to concurrently evaluate single-agent and combination regimens in glioblastoma.
Looking Forward to a New Wave of Breast Cancer TherapiesMay 14th 2020
The degree to which nature and nurture affect disease has long been debated in medicine, and it is an issue that esteemed breast cancer researcher and medical oncologist Joyce A. O’Shaughnessy, MD, has been working to unravel for her patients throughout a career that spans more than 30 years.
Oncology Clinical Trials Should Reflect Molecular Advances, Real-World PatientsMay 11th 2020
From the earliest moments of medical school instruction, through residency and fellowship training, physicians are taught the primacy of the randomized phase 3 trial in the hierarchy of evidence-based medicine.